Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia

Autor:	Oliveira, J. P., Lobão, B., Machado-De-Sousa, J. P., Baker, G. B., Dursun, S., Hallak, J. E.
Zdroj:	ResearcherID
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1c5402a2367735e295f2abf8d7519ee8 https://www.ncbi.nlm.nih.gov/pubmed/21971773 Zobrazit plný text záznamu